ClinicalTrials.Veeva

Menu
A

Arizona Arthritis & Rheumatology Research, PLLC | Phoenix, AZ

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Methotrexate
Baricitinib
Ixekizumab
Vedolizumab
Upadacitinib
Iloprost
Adalimumab
Mirikizumab
Canakinumab
Secukinumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

8 of 29 total trials

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with cutaneous lupus erythematosus (CLE)....

Enrolling
Subacute Cutaneous Lupus Erythematosus
Chronic Cutaneous Lupus Erythematosus
Drug: Litifilimab
Drug: Placebo

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Enrolling
Crohn's Disease
Drug: Mirikizumab
Status recently updated

This study aims to examine the efficacy and safety of obexelimab for the prevention of flare of IgG4-related disease (IgG4-RD)

Enrolling
Active, not recruiting
IgG4 Related Disease
Drug: Obexelimab
Other: Placebo

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous throm...

Enrolling
Rheumatoid Arthritis
Drug: Baricitinib
Drug: TNF Inhibitor

CDPATH™ is a tool to help predict the potential for developing Crohn's disease related complications in certain adult participants within 3 years. Th...

Active, not recruiting
Crohn's Disease
Other: Blood Draw
Other: CDPATH™

The main purpose of this study is to assess the safety and efficacy of peresolimab in adult participants with moderately-to-severely active rheumatoi...

Active, not recruiting
Joint Diseases
Arthritis
Drug: Peresolimab
Drug: Placebo

The COVID-19 VaccinE Response in Rheumatology patients (COVER) study is a multicenter randomized controlled trial designed to evaluate the efficacy a...

Enrolling
Psoriatic Arthritis
Spondylarthritis
Drug: Abatacept
Drug: Baricitinib
Locations recently updated

Systemic Lupus Erythematosus (SLE) is an immune-mediated disease associated with inflammation of multiple organ systems. This study will assess how s...

Enrolling
Systemic Lupus Erythematosus
Drug: Upadacitinib
Drug: Placebo

Trial sponsors

Lilly logo
Takeda logo
Bristol-Myers Squibb (BMS) logo
E
AbbVie logo
Amgen logo
A
AstraZeneca logo
Biogen logo
G

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems